Hrefna Gudmundsdottir

Company: European Medicines Agency

Job title: Chief Medical Officer

Seminars:

Workshop E: A Regulatory Perspective: Understanding the Approach Towards Selecting Efficacy Endpoints for Rare Disease Clinical Trials 11:30 am - 2:30 pm

Attend this workshop to better understand how to demonstrate clinically meaningful and statistically significant endpoints to identify the windows of opportunity for the future treatments of IgAN, FSGS and ADPKD. Harmonizing global regulations to standardize endpoints for rare and genetic kidney diseases Developing disease-specific endpoints for rare kidney diseases with different phenotypic presentations and disease pathology  Navigating endpoints beyond total kidney…Read more

day: Workshop Day Track B